Fingerprint
Dive into the research topics of 'CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma [Figure presented]'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically